… Other independent predictors of cost included stroke severity, heparin treatment, atrial
fibrillation, male sex, ischemic cardiac disease, and premorbid functional status. …

… Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after
total hip replacement: A randomised, double-blind, non-inferiority trial. Lancet 2007 …

… The ROCKET AF trial recruited atrial fibrillation patients at high risk for ischemic stroke. In
the subpopulation (n=6983) included in the current analysis, the mean age was 71 years (…

… stroke in patients with atrial fibrillation. We designed the … Evaluation in secondary Stroke
Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate …

… review discusses the current state of coumarin pharmacogenetics, the evidence from recent
randomized controlled trials and economic evaluations … to chronic atrial fibrillation and …

… review article, we will focus on stroke prevention in AF, and the clinical impact of CKD and its
implications for management… world' atrial fibrillation population: a modelling analysis based …

… To assess the association between LAVI and detection of atrial fibrillation in patients with
ESUS, we performed a multivariate regression analysis adjusting for age. Our analysis was …

… Atrial fibrillation (AF) is the most frequent arrhythmia encountered in clinical practice and
is … In this article, we review the available data regarding the prognostic role of RDW in AF …

… Direct Oral Anticoagulants (DOACs) are recommended as first-line treatment in atrial
fibrillation (AF) patients. Despite their benefits and effectiveness, several patients experience …

… We categorized PES as follows: atrial cardiopathy, atrial fibrillation diagnosed during follow‐up,
arterial disease, left ventricular disease, cardiac valvular disease, patent foramen ovale, …